Wednesday, December 31, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Smokers Need More Support to Quit – IPU

IPN by IPN
5 March 2019
in News
0

Medical Card Patients should have access to Nicotine Replacement Therapy (NRT) direct from pharmacies to encourage more people to quit. This call was made by the Irish Pharmacy Union (IPU), ahead of National No Smoking Day, who say providing this service would reduce an unnecessary barrier to NRT and encourage more people to quit.

NRT is designed to reduce the physical symptoms associated with stopping smoking. It involves a consultation with a healthcare profession such as a pharmacist, who will understand the patient’s smoking habits and recommend suitable nicotine replacements for that patient.

NRT is available in pharmacies nationwide without prescription for private patients. However, despite the IPU providing a detailed proposal to the Department of Health in 2017, medical card patients are still unable to access this vital treatment direct from their pharmacies; they must still go to their GP to get a prescription.

Tomás Conefrey, a pharmacist and a member of the IPU said, “Over one in five (22.7%) people aged 15 years and over smoke in Ireland. Smoking prevalence is higher in men (24.3%) than women (21.2%). In addition, 19% of people are daily and 4% are occasional smokers.  Thankfully, however, the smoking rate in Ireland has been falling in recent years, but the rate of decline has not been fast enough. At its current rate we would not see it fall below 5% until 2052. It is clear we need to think differently about how we support people to quit smoking.

“NRT works, and the more accessible it is the more likely people will be to avail of treatments. We know that smoking is highest among the lowest socio-economic groups and there is simply no reason why a medical card patient should require a prescription to access NRT and the over-the-counter products that private patients successfully receive from pharmacies.

“Over half, 57%, of current smokers are thinking about quitting. The Government has a responsibility to maximise the availability of supports to all of those with ambitions to quit, not just private patients.  This is a scheme that can be easily and quickly be implemented as all it requires is a decision to do so.”

 

National No Smoking Day, 6th March 2019

Previous Post

McCauley Pharmacy Commits €100,000 to Wexford GAA Wellness Programme

Next Post

Ireland’s Best in OTC Products 2019

Next Post

Ireland’s Best in OTC Products 2019

Leave a Reply

Your email address will not be published. Required fields are marked *

ALONE Urges Government to Reconsider Pharmacy Changes Including Blister Packs

ALONE Urges Government to Reconsider Pharmacy Changes Including Blister Packs

16 December 2025
Migraine Ireland launches the Irish Headache Society to advance migraine and headache care in Ireland.

Migraine Ireland Launches First Multidisciplinary Irish Headache Society

8 December 2025
Boots Ireland launches Common Conditions Service allowing pharmacists to prescribe for the first time.

Boots Ireland Unveils Groundbreaking Common Conditions Service, Empowering Pharmacists to Prescribe for the First Time

8 December 2025

RECOMMENDED NEWS

JAMA Dermatology Publishes Data Showing upadacitinib Achieved Superiority Versus dupilumab for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis

JAMA Dermatology Publishes Data Showing upadacitinib Achieved Superiority Versus dupilumab for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis

4 years ago
Webinar: Overview of immunity and its link to gut health, Professor O’Neill – Sign up below

Webinar: Management of Allergic Rhino-Conjunctivitis

5 years ago

New phase of the COVID-19 communications campaign to encourage safe behaviours as we learn to live with COVID-19.

5 years ago

Awareness campaign on psoriatic arthritis

5 years ago

test-sponsored-ad-jan-2026

Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN